Enable Biosciences
Company Snapshot
Issuer Type
private
Issuer Industry
Biotechnology
Entity Type
Equity
Highlights
- We create ultrasensitive analytical tools
- Determine your level of neutralizing antibodies
- Enable-supported CalScope Serosurvey Program
- Develops ultrasensitive and multiplex immunoassays
Investment Opportunity
Enable Biosciences is a South San Francisco-based diagnostics company. We develop ultrasensitive immunoassays that permit early detection and treatment of autoimmune and infectious diseases. We’re a team of scientists, engineers, and clinicians creating the next generation of tools for predictive medicine. Spun out of UC Berkeley and Stanford in 2016, we’ve partnered with Stanford Healthcare, Harvard Medical School, California Department of Public Health, JDRF, and many others. With over 150,000 tests performed, we enable your future.
Offering
Offering Type
Equity
Minimum Offering Amount
$600,000
Minimum Individual Investment
$25,000
Maximum Offering Amount
$3,000,000
Offering Company Location
510 Myrtle Ave
Suite 101
South San Francisco,
California 94080
Materials Available in Offering Portal
Management
| Officers | |||
|---|---|---|---|
| Name | Title | Compensation Information Available | |
| David Seftel | Chief Executive Officer |  |
|
| Peter Robinson | Secretary | |
|
| David Seftel | Chief Financial Officer | |
|
| Directors | |||
|---|---|---|---|
| Name | Title | Compensation Information Available | |
| David Seftel | Director | |
Service Provider Relationships In Place
Accountant
Legal Counsel
Second Market Certification
This offering company is not yet Second Market Certified with Glass Box.